TENS and EMS Treatment for Diabetic Peripheral Neuropathy.

Context: Diabetic peripheral neuropathy (DPN) is a common complication occurring in both type 1 and type 2 diabetics. DPN may result in foot ulceration or lower-limb amputation. Objective: This case was undertaken to evaluate the efficacy of ReBuilder® therapy in the treatment of diabetic peripheral neuropathy. Methods: The case report is based on 3 selected patients, 2 males and 1 female. Each patient continued being managed by his/her primary care physician. No changes to allopathic medicine or diet were advised by our team. In addition to the allopathic therapy, we added ReBuilder® therapy, low level light therapy, vibration therapy and supplementation. The treatment period ranged from 17 to 20 weeks. Conclusion: The data presented here show promise for future, larger, controlled studies on the use of ReBuilder® devices for the treatment of diabetic peripheral neuropathy pain.

Avian influenza A (H5N1) infection with respiratory failure and meningoencephalitis in a Canadian traveller.

In an urban centre in Alberta, an otherwise healthy 28-year-old woman presented to hospital with pleuritic chest and abdominal pain after returning from Beijing, China. After several days, this was followed by headache, confusion and, ultimately, respiratory failure, coma and death. Microbiology yielded influenza A subtype H5N1 from various body sites and neuroimaging was consistent with meningoencephalitis. While H5N1 infections in humans have been reported in Asia since 1997, this is the first documented case of H5N1 influenza in the Western Hemisphere. The present case demonstrated the typical manifestation of H5N1 influenza but, for the first time, also confirmed previous suggestions from human and animal studies that H5N1 is neurotropic and can manifest with neurological symptoms and meningoencephalitis.

Dans un centre urbain de l'Alberta, une femme auparavant en santé de 28 ans s'est rendue à l'hôpital en raison d'une douleur pleurétique et abdominale à son retour de Beijing, en Chine. Quelques jours plus tard, cette douleur a été suivie de céphalées et de confusion, puis la patiente a souffert d'une insuffisance respiratoire, d'un coma et est décédée. La microbiologie de divers sièges a révélé une grippe H5N1 de sous-type A, et la neuro-imagerie a corroboré la présence d'une méningoencéphalite. Des infections par la grippe H5N1 sont signalées chez les humains depuis 1997 en Asie, mais il s'agit du premier cas démontré dans l'hémisphère occidental. Ce cas présentait la forme classique de la grippe H5N1, mais pour la première fois, il confirmait également ce que laissaient entrevoir les études sur des humains et des animaux, soit que la grippe H5N1 est neurotrope et peut se manifester par des symptômes neurologiques et une méningoencéphalite.